rapeutic efficiency of iodine 131 in thyroid adenoma-About 59 cases

ABSTRACT

Our study dealt with 81 patients treated by iodine 131 for autonomous goiter. We have followed 59 patients during a year approximately.The global therapeutic efficiency is of 73% and the risk of hypothyroidism is very weak. The administration of a high activity [> 15mCi] of iodine allows go get a faster recovery, a better therapeutic efficiency and permits to reduce the number of cures [therefore, to reduce the irradiation of the disease], nevertheless, the risk of hypothyroidism is very slight. The advantages of metabolic rediotherapy [low cost, facility of administration, efficiency] make it preferable to surgery, above all with patients that are more than 40 years old, for whom the radiation risk is practically of no account [hereditary diseases, cancer]